10-panel combined drug test: amphetamine (AMP500), cocaine (COC300), marijuana (THC50), methamphetamine (MET500), morphine (MOP300), phencyclidine (PCP25), benzodiazepines (BZO300), ecstasy (MDMA500), methadone (MTD300), barbiturates (BAR300) in urine

01

The buyer is procuring a combined urine drug screening test that detects ten substances in a single test: amphetamine at 500 ng/ml, cocaine at 300 ng/ml, marijuana (THC) at 50 ng/ml, methamphetamine at 500 ng/ml, morphine at 300 ng/ml, phencyclidine at 25 ng/ml, benzodiazepines at 300 ng/ml, ecstasy (MDMA) at 500 ng/ml, methadone at 300 ng/ml and barbiturates at 300 ng/ml. Suppliers submitting a price offer confirm that the goods offered do not originate from the Russian Federation, the Republic of Belarus or the Islamic Republic of Iran.

02

Description

03

Recent awards

• Sodium metamizole injection solution 500 mg/ml, 2 ml; Hydroxyethyl starch 6%, 200 ml; Paracetamol infusion solution 10 mg/ml, 100 ml; Enoxaparin sodium injection solutions; Omeprazole 40 mg vials; Cefazolin powder for injections 1 g; Ondansetron injection solution

  awarded to Товариство з обмеженою відповідальністю "Юрія-фарм"

• 10-panel urine drug test: amphetamine (AMP500)/cocaine (COC300)/marijuana (THC50)/methamphetamine (MET500)/morphine (MOP300)/phencyclidine (PCP25)/benzodiazepines (BZO300)/ecstasy (MDMA500)/methadone (MTD300)/barbiturates (BAR300)

  awarded to Товариство з обмеженою відповідальністю "ЕКСДІА ПЛЮС"

• 10-drug combined urine test: amphetamine (AMP500)/cocaine (COC300)/marijuana (THC50)/methamphetamine (MET500)/morphine (MOP300)/phencyclidine (PCP25)/benzodiazepines (BZO300)/ecstasy (MDMA500)/methadone (MTD300)/barbiturates (BAR300)

  awarded to Товариство з обмеженою відповідальністю "ЕКСДІА ПЛЮС"

05

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€11,445,040

10,058 open across Europe right now

Buyer track record on Aperlena

50 notices tracked · 43 awarded